These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23617305)

  • 21. Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge.
    Raffaeli G; Pokorna P; Allegaert K; Mosca F; Cavallaro G; Wildschut ED; Tibboel D
    Front Pediatr; 2019; 7():360. PubMed ID: 31552205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basics and dynamics of neonatal and pediatric pharmacology.
    Seyberth HW; Kauffman RE
    Handb Exp Pharmacol; 2011; 205():3-49. PubMed ID: 21882104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review.
    Yalçin N; Flint RB; van Schaik RHN; Simons SHP; Allegaert K
    Pharmgenomics Pers Med; 2022; 15():675-696. PubMed ID: 35795337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.
    Naji-Talakar S; Sharma S; Martin LA; Barnhart D; Prasad B
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):273-289. PubMed ID: 33256492
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic drug monitoring--the appropriate use of drug level measurement in the care of the neonate.
    Young TE
    Clin Perinatol; 2012 Mar; 39(1):25-31. PubMed ID: 22341534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of Phase I Metabolism of Drugs.
    Allegaert K; van den Anker J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S33-S41. PubMed ID: 31502685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal clinical pharmacology: recent observations of relevance for anaesthesiologists.
    Allegaert K; de Hoon J; Naulaers G; Van De Velde M
    Acta Anaesthesiol Belg; 2008; 59(4):283-8. PubMed ID: 19235528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.
    Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN
    Clin Pharmacokinet; 2020 Apr; 59(4):501-518. PubMed ID: 31587145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling.
    Wang J; Edginton AN; Avant D; Burckart GJ
    J Clin Pharmacol; 2015 Oct; 55(10):1175-83. PubMed ID: 25907280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Pediatric Modeling and Simulation Using Ontogeny Information.
    Ince I; Solodenko J; Frechen S; Dallmann A; Niederalt C; Schlender J; Burghaus R; Lippert J; Willmann S
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S95-S103. PubMed ID: 31502689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics in the newborn.
    Alcorn J; McNamara PJ
    Adv Drug Deliv Rev; 2003 Apr; 55(5):667-86. PubMed ID: 12706549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics and renal drug disposition in the newborn.
    Kapur G; Mattoo T; Aranda JV
    Semin Perinatol; 2004 Apr; 28(2):132-40. PubMed ID: 15200252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
    Björkman S
    Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug metabolism in early infancy: opioids as an illustration.
    Van Donge T; Mian P; Tibboel D; Van Den Anker J; Allegaert K
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):287-301. PubMed ID: 29363349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonates are not just little children and need more finesse in dosing of antibiotics.
    Allegaert K; van den Anker J
    Acta Clin Belg; 2019 Jun; 74(3):157-163. PubMed ID: 29745792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.
    Rostami-Hodjegan A
    Clin Pharmacol Ther; 2012 Jul; 92(1):50-61. PubMed ID: 22644330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental pharmacokinetics.
    van den Anker JN; Schwab M; Kearns GL
    Handb Exp Pharmacol; 2011; 205():51-75. PubMed ID: 21882105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.